1. Pancreatic neuroendocrine tumors
   Jian Sun, 2017, IRDR CrossRef
2. Treatment options for PNET liver metastases: a systematic review
   Giuseppe Nigri et al, 2018, World J Surg Onc CrossRef
3. Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases
   Si Shi et al, 2018, WJG CrossRef
4. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
   Jun-Xi Xiang et al, 2018, Ann Surg Oncol CrossRef
5. A modified M-stage classification based on the metastatic patterns of pancreatic neuroendocrine neoplasms: a population-based study
   Xianbin Zhang et al, 2018, BMC Endocr Disord CrossRef
6. The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer
   Wei-Fu Lv et al, 2017, Medicine CrossRef
7. Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
   Guopei Luo et al, 2017, Oncol Lett CrossRef
8. The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)
   Wenming Wu et al, 2021 CrossRef
9. Liver metastases.
   Diamantis I Tsilimigras et al, 2021, Nat Rev Dis Primers CrossRef
10. Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER-based analysis of 15,836 cases.
    Ningzhen Fu et al, 2021, Cancer Med CrossRef
11. Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis
    Thomas M. Pausch et al, 2021, Cancers CrossRef
12. nnSurgical management for pancreatic neuroendocrine neoplasms with synchronous hepatic metastases: a literature review
    Bohui Yin et al, 2022, Surgery in Practice and Science CrossRef
13. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
    Feng Yin et al, 2022, WJG CrossRef
14. Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
    Jianwei Zhang et al, 2021, Neuroendocrinology CrossRef
15. Multimodal therapy with aggressive hepatectomy, everolimus, and octreotide for metastatic pancreatic neuroendocrine neoplasm enables 10-year survival
    Shinsei Yumoto et al, 2022, Clin J Gastroenterol CrossRef
16. Synchronous primary duodenal papillary adenocarcinoma and gallbladder carcinoma: A case report and review of literature
    Jing Chen et al, 2022, WJCC CrossRef
17. Advances in the treatment of gastroenteropancreatic neuroendocrine neoplasms with somatostatin analogs
    Ming Lu et al, 2023 CrossRef
18. Surgical management of pancreatic neuroendocrine neoplasms
    Piero Alberti et al, 2023, Laparoscopic, Endoscopic and Robotic Surgery CrossRef
19. Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms
    Feng Jiao et al, 2023 CrossRef
20. Decreasing utilization of surgical interventions amongst patients with pancreatic neuroendocrine tumor with liver metastases
    Neda Amini et al, 2024, The American Journal of Surgery CrossRef
21. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors
    Jing-Yuan Ye et al, 2023, Eur Radiol CrossRef
22. Ectopic Adrenocorticotropic Hormone Syndrome due to Pancreatic Neuroendocrine Carcinoma: A Case Report
    Aya Kawanishi et al, 2024, Intern. Med. CrossRef